Human Siglec-9 Antibody, R&D Systems™

Siglec-9

LYOPH

Western Blot, Flow Cytometry, Neutralization, CyTOF, ELISA

Unconjugated

Mouse

Human

Q9Y336

27180

Mouse myeloma cell line NS0-derived recombinant human Siglec-9 Gln18-Gly348 (predicted) Accession # Q9Y336

Primary

Reconstitute at 0.5 mg/mL in sterile PBS.

Detects human Siglec-9 in direct ELISAs and Western blots. In direct ELISAs, less than 10% cross-reactivity with recombinant mouse Siglec-E is observed and less than 1% cross-reactivity with recombinant human (rh) Siglec-3, rhSiglec-5, rhSiglec-6, rhSiglec-7, rhSiglec-8 or rhSiglec-10 is observed. In Western blots, approximately 100% cross-reactivity with recombinant mouse Siglec-E is observed under non-reduced conditions.

191240

Western Blot 1 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, Neutralization 0.015-0.075 ug/mL, CyTOF-ready, ELISA Capture (Matched Antibody Pair) 2-8 ug/mL

Monoclonal

Purified

RUO

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

CD329, CDw329, FOAP-9, OBBP-Like, Protein FOAP-9, sialic acid binding Ig-like lectin 9, sialic acid-binding Ig-like lectin 9, siglec-9, Siglec9

SIGLEC9

IgG2a

Protein A or G purified from hybridoma culture supernatant

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.